Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new
cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …

Simple Summary Colorectal cancer (CRC) is a leading cause of death among cancer
patients, and the liver is the most common visceral metastatic site. Despite promising …

The liver is a common site of cancer metastases. Systemic therapy is widely accepted as the
standard treatment for liver metastases (LM), although select patients with liver …

Objectives Optimizing a machine learning (ML) pipeline for radiomics analysis involves
numerous choices in data set composition, preprocessing, and model selection. Objective …

Purpose To characterize estimated absorbed tumor dose (AD T), objective response (OR),
and estimated target dose of liver metastatic colorectal cancer (mCRC) after resin …

Hepatocellular carcinoma (HCC) with portal vein tumor thrombus is considered an
advanced stage disease. Non-surgical local and systemic therapies are the only treatment …

Introduction Liver-dominant metastatic colorectal cancer is noted in approximately 20%–
35% of the patients. Systemic chemotherapy remains the first-line treatment for mCRC, but …

Methods: We evaluated current clinical developments and outcomes of SIRT in Germany
based on standardized hospital discharge data, provided by the German Federal Statistical …

Colorectal malignancy is the third most common cancer and one of the prevalent causes of
death globally. Around 20-25% of patients present with metastases at the time of diagnosis …

Die transarterielle Radioembolisation (TARE) mit radioaktiv markierten Mikrosphären dient
der gezielten Therapie primärer und sekundärer Lebertumore. Bei 90 Y-markierten Glas …